| abstract |
The invention relates to the use in human medicine of hydroxymaterezinol to prevent the onset of cancers, non-cancer, hormone-dependent diseases and / or cardiovascular diseases. As a result, the level of enterolactone or another metabolite of hydroxymaterezinol in human serum increases, thus preventing cancers, non-cancer, hormone-dependent diseases, and / or cardiovascular diseases in humans based on hydroxymalizinol. The invention also relates to pharmaceutical preparations, food supplements and food products containing hydroxymaterezinol. |